SFVAX — AIG Strategic Value Fund
Data updated: 2021-06-29
SFVAX — AIG Strategic Value Fund. Global (incl. US) Multi-Cap / All-Cap Value Equity · $194.82M AUM. Holdings, fees, performance and SEC filings.
SFVAX Fund Overview
SFVAX — AIG Strategic Value Fund is a US mutual fund managed by Sunamerica Series, Inc., categorised as Global (incl. US) Multi-Cap / All-Cap Value Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Sunamerica Series, Inc.
- Category: Global (incl. US) Multi-Cap / All-Cap Value Equity
- Assets under management: $194.82M
- 1-year return: 41.7%
- Ticker: SFVAX
- SEC CIK: 0001020861
- SEC series ID: S000007588
- Share class ID: C000020676
SFVAX Investment Objective and Strategy
AIG Strategic Value Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Sunamerica Series, Inc..
Investment objective
The investment goal of the AIG Strategic Value Fund (the Fund) is long-term growth of capital.
Principal investment strategy
The Funds principal investment strategy is based on value. The value oriented philosophy to which the Fund subscribes is that of investing in securities believed to be undervalued in the market. The selection criteria is usually calculated to identify stocks of companies with solid financial strength that have attractive valuations ( e.g. , as measured by low price earnings ratios) and that may have generally been overlooked by the market. The principal investment technique of the Fund is to employ a buy and hold strategy with equity securities selected annually from the Russell 3000 Value Index. The portfolio managers select securities through extensive quantitative research, which includes the use of a multi-factor model that the portfolio managers employ to identify and rank companies within the Russell 3000 Value Index.
Through this selection process, the portfolio managers will select approximately 100 securities from the Russell 3000 Value Index. The selection criteria for these securities will generally include a combination of factors that relate to profitability and valuation. The process also includes the use of a multi-factor model that is designed to control the portfolios volatility relative to the Russell 3000 Value Index. While the securities selection process will take place on an annual basis, the portfolio managers may, at their discretion, substitute certain securities for those selected for the Fund or reduce the position size of a portfolio security in between the annual rebalancings, under certain limited circumstances. These circumstances will generally include where a security held by the Fund becomes a disproportionately large percentage of the Funds holdings or when the security substantially underperforms relative to the Russell 3000 Value Index.
The Fund will be evaluated and adjusted at the discretion of the portfolio managers on an annual basis. The annual consideration of the securities that meet the selection criteria will take place on or about March 1. The Fund employs a strategy to hold securities between its annual rebalancings, even if there are adverse developments concerning a particular security, an industry, the economy or the stock market generally.
SFVAX Performance
Total returns for SFVAX (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 41.7% |
SFVAX Risk Information
Risk metrics for SFVAX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.3%
SFVAX Costs and Fees
SFVAX costs about $150 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.50%
- Gross expense ratio: 1.50%
- Portfolio turnover: 47%
- Brokerage commissions: 4.40 bps of average net assets (SEC N-CEN)
SFVAX Cashflows
Over the 12 months to 2021-04, AIG Strategic Value Fund had net outflows of $24.98M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2021-04 | −$2.31M |
| 2021-03 | −$1.32M |
| 2021-02 | −$1.79M |
| 2021-01 | −$4.85M |
| 2020-12 | $602.63K |
| 2020-11 | −$1.44M |
SFVAX Debt Constituents
No individual debt constituents are reported in AIG Strategic Value Fund's latest SEC N-PORT filing.
SFVAX Prospectus and SEC Filings
Official AIG Strategic Value Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2021-02-26
- Prospectus (485BPOS) — filed 2020-03-11
- Prospectus supplement (497) — filed 2021-03-03
- Portfolio holdings (N-PORT) — filed 2021-06-29
- Portfolio holdings (N-PORT) — filed 2021-03-31
- Portfolio holdings (N-PORT) — filed 2020-12-22
- Annual census (N-CEN) — filed 2021-01-14
- Annual census (N-CEN) — filed 2020-01-13
Related Funds
Other Global (incl. US) Multi-Cap / All-Cap Value Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.